Biobank
Ended Awarded Last action
- Contract number
- HHSN26100042
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $25,652,545
Award facts
- Opportunity
-
- N01CO5240180 Solicitation number
- Operations and Technical Support for the Frederick National Laboratory for Cancer Research (FLNCR), a Federally Funded Research and Development Center (FFRDC) Award Notice · Posted Apr 27, 2015
- Contract value 100% obligated
- $25,652,545.00 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 561210 Facilities Support Services
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | -$1,103,566 | |
| Terminate for Convenience | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Change Order | -$13,243,141 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $39,999,252 |
About this award
This federal contract award is for the BIOBANK project, which is implementing the President's Department of Government Efficiency Cost Efficiency Initiative. The $25,652,545.00 cost-plus-fixed-fee delivery order contract was awarded to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc., by the National Cancer Institute (NCI), a civilian agency. The contract, which does not have a set-aside designation, runs through June 30, 2027 and covers a range of biomedical research and facilities support services, including clinical trials management, vaccine development, and specialized laboratory testing. Leidos Biomedical Research Inc. has extensive experience as a Federally Funded Research and Development Center (FFRDC) contractor for the NCI, supporting critical scientific research across disease areas such as cancer, HIV/AIDS, influenza, COVID-19, and gene therapy.
Quick answers
Who was awarded contract HHSN26100042?
HHSN26100042 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 28, 2017.
How much is contract HHSN26100042 worth?
The government has obligated $25,652,545 on HHSN26100042.
Is contract HHSN26100042 an order under another contract?
Yes. HHSN26100042 is a delivery order under HHSN261201500003I, an indefinite delivery contract.
Was contract HHSN26100042 competed?
The extent of competition for HHSN26100042 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award